Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Jinyu Bio-technology Co., Ltd.
  6. Summary
    600201   CNE000000Y37

JINYU BIO-TECHNOLOGY CO., LTD.

(600201)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
15.66 15.17 15.2 15.45 15.33 Last
7552998 12843470 9131417 10725490 6735502 Volume
-0.76% -3.13% +0.20% +1.64% -0.78% Change
Estimated financial data (e)
Sales 2021 2 144 M 332 M 332 M
Net income 2021 646 M 99,8 M 99,8 M
Net cash position 2021 1 237 M 191 M 191 M
P/E ratio 2021 26,8x
Yield 2021 1,14%
Sales 2022 2 767 M 428 M 428 M
Net income 2022 928 M 144 M 144 M
Net cash position 2022 1 745 M 270 M 270 M
P/E ratio 2022 18,6x
Yield 2022 1,61%
Capitalization 17 147 M 2 652 M 2 652 M
EV / Sales 2021 7,42x
EV / Sales 2022 5,57x
Nbr of Employees 1 444
Free-Float 80,4%
More Financials
Company
JINYU BIO-TECHNOLOGY CO., LTD. formerly INNER MONGOLIA JINYU GROUP CO., LTD, is a China-based company, principally engaged in the research and development, manufacture and sales of veterinary biopharmaceuticals. The Company mainly provides veterinary vaccines. The Company is also engaged in textile processing business, and the provision of property leasing and management activities. The Company also provides energy... 
Sector
Pharmaceuticals
Calendar
10/22Earnings Release
More about the company
Ratings of Jinyu Bio-technology Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about JINYU BIO-TECHNOLOGY CO., LTD.
08/26Jinyu Bio-Technology Co., Ltd. Reports Earnings Results for the Half Year End..
CI
07/07Jinyu Bio-technology Co., Ltd. announced that it expects to receive CNY 900.0..
CI
06/21JINYU BIO-TECHNOLOGY CO., LTD.(XSSC : 600201) dropped from S&P Global BMI Index
CI
06/14JINYU BIO-TECHNOLOGY CO., LTD.(SHSE : 600201) dropped from Shanghai Stock Exchan..
CI
06/14JINYU BIO-TECHNOLOGY CO., LTD.(XSSC : 600201) dropped from FTSE All-World Index
CI
04/22Jinyu Bio-Technology Co., Ltd. Reports Earnings Results for the First Quarter..
CI
2020Jinyu Bio-Technology Co., Ltd. Reports Earnings Results for the Nine Months E..
CI
2020Jinyu Bio-Technology Co., Ltd. Reports Earnings Results for the Half Year End..
CI
2020Jinyu Bio-technology Co., Ltd. Announces Cash Dividend for 2019, Payable on J..
CI
2020Tranche Update on Jinyu Bio-technology Co., Ltd.'s Equity Buyback Plan announ..
CI
2020Jinyu Bio-technology Co., Ltd.'s Equity Buyback announced on July 30, 2019, h..
CI
2020Jinyu Bio-Technology Co., Ltd. Reports Earnings Results for the First Quarter..
CI
2020Jinyu Bio-Technology Co., Ltd. Reports Earnings Results for the Full Year End..
CI
2020Jinyu Bio-Technology Co., Ltd. Provides Earnings Guidance for the Year 2019
CI
2019JINYU BIO-TECHNOLOGY CO., LTD.(SHSE : 600201) added to Shanghai Stock Exchange 1..
CI
More news
News in other languages on JINYU BIO-TECHNOLOGY CO., LTD.

- No features available -

More news
Chart JINYU BIO-TECHNOLOGY CO., LTD.
Duration : Period :
Jinyu Bio-technology Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JINYU BIO-TECHNOLOGY CO., LTD.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 15,33 CNY
Average target price 26,43 CNY
Spread / Average Target 72,4%
EPS Revisions
Managers and Directors
Jing Zhang General Manager, Director & Vice President
Chong Yu Zhang Chairman & President
Min Peng Chief Financial Officer
Guo Ying Liu Chairman-Supervisory Board
Yong Hong Chen Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JINYU BIO-TECHNOLOGY CO., LTD.-26.62%2 652
ZOETIS INC.19.93%94 073
ELANCO ANIMAL HEALTH INCORPORATED5.64%15 326
DECHRA PHARMACEUTICALS PLC48.70%7 636
VIRBAC58.19%3 729
SWEDENCARE AB (PUBL)137.54%2 099